Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA. [electronic resource]
Producer: 20120723Description: e31990 p. digitalISSN:- 1932-6203
- Adult
- Antiviral Agents -- pharmacology
- Cohort Studies
- DNA -- metabolism
- DNA Primers -- genetics
- DNA, Viral -- genetics
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Leukocytes, Mononuclear -- cytology
- Male
- Middle Aged
- Pyrrolidinones -- pharmacology
- Raltegravir Potassium
- Real-Time Polymerase Chain Reaction -- methods
- Terminal Repeat Sequences
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.